Claudin-2 protein helps infant mice absorb more calcium from breast milk

A key protein known as claudin-2, which lines the intestinal epithelial cells of infant mice, helps them absorb more calcium from breast milk, according to a new study in the journal Function. Researchers from the University of Alberta in Canada also discovered a hormone in breast milk-;called epidermal growth factor-;causes the intestine to produce more claudin-2. As a result, epidermal growth factor in breast milk enhances calcium absorption in young mice.

Infants and children need to absorb minerals such as calcium from their diet to build strong bones during growth and development. Babies born prematurely are at risk of low bone mineralization.

This study provides key knowledge of how infants meet their high calcium requirements to enable growth, and how a factor in breast milk helps increase calcium absorption. These findings contribute a molecular understanding that could be potentially manipulated to improve bone health."

R. Todd Alexander, PhD, first author of the study

Source:
Journal reference:

Beggs, M. R., et al. (2023). Maternal Epidermal Growth Factor Promotes Neonatal Claudin-2 Dependent Increases in Small Intestinal Calcium Permeability. Function. doi.org/10.1093/function/zqad033.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Targeted degradation of Pin1 shows promise for pancreatic cancer treatment